Tag: revive-therapeutics-ltd

Investment Services & Trading

Revive Therapeutics Ltd. Submits IND Application to the US FDA for the Clinical Development of Bucillamine for the Treatment of Gout

October 30, 2014
Presse

TORONTO, ONTARIO -- (Marketwired) -- 10/30/14 -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) ("Revive" or the…

Continue Reading
Investment Services & Trading

Revive Therapeutics Ltd. Applies for Orphan Drug Designation to FDA for Treatment of Rett Syndrome

October 28, 2014
Presse

TORONTO, ONTARIO -- (Marketwired) -- 10/28/14 -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) ("Revive" or the…

Continue Reading
Investment Services & Trading

Revive Therapeutics Ltd. Announces Results for Fiscal Year Ended June 30, 2014

September 16, 2014
Presse

TORONTO, ONTARIO -- (Marketwired) -- 09/16/14 -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE:…

Continue Reading